Upregulates VEGF, FGF-2, matrix metalloproteinase, and MCP-1 production; central to NLRP3 inflammasome activation; drives arterial inflammation and endothelial damage and leads to obesity. This evidence concerns the gene FGF2 and obesity due to melanocortin 4 receptor deficiency.